ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

33,158Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 2456

$2.07M Total Retail Price of All Prescriptions

Rank: 5 out of 2456

621 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 621 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 621 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 27,197 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

53 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 2,225 2,029 1 9
SIMVASTATIN 1,256 1,009 2 2
METOPROLOL TARTRATE 1,143 986 3 10
FUROSEMIDE 1,132 1,012 4 8
LISINOPRIL 1,033 791 5 1
LEVOTHYROXINE SODIUM 993 843 6 4
TRAZODONE HCL 799 654 7 17
GABAPENTIN 719 546 8 16
OLANZAPINE 704 559 9 57
OMEPRAZOLE 626 521 10 3
MIRTAZAPINE 625 599 11 29
AMLODIPINE BESYLATE 595 531 12 5
CITALOPRAM HBR 583 542 13 14
RISPERIDONE 575 394 14 50
DIVALPROEX SODIUM 541 460 15 51
ATENOLOL 510 428 16 6
DONEPEZIL HCL 493 493 17 23
QUETIAPINE FUMARATE 435 392 18 47
NAMENDA 435 415 18 42
METFORMIN HCL 384 301 20 11
CLOZAPINE 349 180 21 75
FAMOTIDINE 320 245 22 84
GEMFIBROZIL 310 236 23 93
LANTUS 310 224 23 44
POTASSIUM CHLORIDE 288 255 25 33
ATORVASTATIN CALCIUM 284 230 26 12
HYDROCODONE-ACETAMINOPHEN 284 215 S3 26 20
TAMSULOSIN HCL 261 204 28 32
NOVOLOG 259 203 29 100
SPIRIVA 250 190 30 43
LEVETIRACETAM 247 190 31 90
GLIPIZIDE 238 203 32 46
ADVAIR DISKUS 230 192 33 36
LAMOTRIGINE 210 139 34 120
BENZTROPINE MESYLATE 208 142 R 35 126
SERTRALINE HCL 208 166 35 21
HYDROCHLOROTHIAZIDE 206 163 37 7
HALOPERIDOL 206 114 37 137
FLUOXETINE HCL 201 130 39 45
PREDNISONE 201 171 39 39
ALLOPURINOL 197 173 41 27
ALENDRONATE SODIUM 195 171 42 19
TRAMADOL HCL 194 146 43 24
FORTICAL 189 176 44 269
POLYETHYLENE GLYCOL 3350 189 149 44 64
ISOSORBIDE MONONITRATE ER 187 153 46 48
RANITIDINE HCL 179 168 47 31
GLYBURIDE 176 130 R 48 40
CYMBALTA 171 139 49 65
LIDODERM 171 159 49 58
METOPROLOL SUCCINATE 170 148 51 13
IPRATROPIUM-ALBUTEROL 160 150 52 85
CLOPIDOGREL 159 134 53 55
LACTULOSE 158 142 54 88
ABILIFY 157 101 55 95
DIGOXIN 154 153 56 49
SEROQUEL 145 130 57 102
CARBAMAZEPINE 138 115 58 155
NYSTATIN 138 126 58 99
PAROXETINE HCL 133 68 60 56
VENLAFAXINE HCL ER 130 100 61 92
PHENYTOIN SODIUM EXTENDED 129 96 62 140
GENERLAC 127 89 63 142
PRAVASTATIN SODIUM 125 89 64 15
ENULOSE 123 87 65 193
DILANTIN 120 104 66 212
SPIRONOLACTONE 117 93 67 73
IBUPROFEN 113 37 68 52
AZITHROMYCIN 109 100 69 60
CARBIDOPA-LEVODOPA 105 105 70 82
NOVOLIN R 105 98 70 173
DIOVAN 104 88 72 26
OXCARBAZEPINE 98 86 73 190
PROPRANOLOL HCL 97 66 74 108
PANTOPRAZOLE SODIUM 96 85 75 37
PLAVIX 94 71 76 79
DILTIAZEM 24HR CD 92 76 77 113
DIVALPROEX SODIUM ER 91 42 78 178
CIPROFLOXACIN HCL 88 82 79 87
CEFPODOXIME PROXETIL 83 75 80 240
FINASTERIDE 82 82 81 66
VENLAFAXINE HCL 82 80 81 188
LEVOFLOXACIN 81 70 83 103
LOVASTATIN 81 81 83 34
TAMIFLU 80 58 85 217
BACLOFEN 79 27 86 112
ESCITALOPRAM OXALATE 73 73 87 116
NOVOLIN N 73 71 87 202
HYDRALAZINE HCL 73 63 87 105
LORAZEPAM 72 72 90 67
HALOPERIDOL DECANOATE 71 39 91 372
SEROQUEL XR 71 63 91 288
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 66 93 147
OXYBUTYNIN CHLORIDE ER 69 63 94 94
ENOXAPARIN SODIUM 68 17 95 186
KLOR-CON M20 68 68 95 69
TRIAMCINOLONE ACETONIDE 68 54 95 131
ROPINIROLE HCL 64 51 98 148
NYSTOP 63 55 99 125
AMANTADINE 61 32 100 379
PROAIR HFA 61 37 100 22
METFORMIN HCL ER 60 34 102 59
OXYCODONE-ACETAMINOPHEN 58 31 S2 103 35
PRIMIDONE 57 45 104 390
OXYBUTYNIN CHLORIDE 57 57 104 152
ESTRADIOL 55 55 R 106 382
LATANOPROST 54 50 107 156
METOCLOPRAMIDE HCL 53 31 108 170
NOVOLOG MIX 70-30 53 31 108 278
CEFTRIAXONE 52 50 110 236
CRESTOR 50 37 111 25
RISPERDAL CONSTA 50 35 111 286
ACTOS 50 32 111 124
NITROFURANTOIN 50 48 111 224
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.